Skip to Content
Epizyme Logo
Contact

Site - Header Menu

  • About
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Collaborations & Partnerships
  • Science
    • Epigenetic Scientific Platform
    • Preclinical Discovery Programs
    • Publications & Presentations
  • Clinical Development
    • Clinical Programs
    • Clinical Trials
    • Expanded Access Policy
    • Investigator Sponsored Trials
    • Medical Education & Sponsorship
  • Medicines
  • Investors & Media
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Annual Report & Proxy
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Corporate Governance Documents
    • Resources
  • Careers

Investors & Media

Site - Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Annual Report & Proxy
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Analyst Coverage
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Corporate Governance Documents
  • Resources
    • Investor FAQs
    • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Mar 30, 2022
Document Date
May 17, 2022
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Epizyme, Inc.
Issuer
Epizyme, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Site - Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Annual Report & Proxy
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Analyst Coverage
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Corporate Governance Documents
  • Resources
    • Investor FAQs
    • Contact

Site - Shareholder Tools

Print Page
Email Alerts
  • Home
  • Privacy Policy
  • Terms of Use
  • Site Map
  • Contact
© 2022 Epizyme, Inc. - All Rights Reserved
▲